Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07695740 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07695740
- Sponsor
- Excyte Biopharma Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-09-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.